Drugs Made In America Acquisition II Corp.
DMIIDrugs Made In America Acquisition II Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger or similar business combination.
Competitors
By market cap
Profile
Drugs Made In America Acquisition II Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger or similar business combination. The company specifically targets acquisition opportunities within the pharmaceutical industry, with a strategic focus on on-shoring domestic manufacturing of critical drugs and active pharmaceutical ingredients to secure the U.S. medical supply chain.
A specialized shell company targeting the U.S. pharmaceutical supply chain and domestic manufacturing technologies.
FAQ
- What is Drugs Made In America Acquisition II Corp.'s market cap?
- Drugs Made In America Acquisition II Corp. (DMII) has a market capitalization of $644.0M and trades on NASDAQ.
- Who are Drugs Made In America Acquisition II Corp.'s competitors?
- Drugs Made In America Acquisition II Corp.'s key competitors include Flag Ship Acquisition Corp. Ordinary Shares, Launch Two Acquisition Corp. Class A Ordinary Shares, Cayson Acquisition Corp Ordinary shares, and others. These companies compete in similar markets and product categories.
- Who does Drugs Made In America Acquisition II Corp. partner with?
- Drugs Made In America Acquisition II Corp.'s notable partners include Cantor Fitzgerald & Co., Continental Stock Transfer & Trust Company.
- Where is Drugs Made In America Acquisition II Corp. headquartered?
- Drugs Made In America Acquisition II Corp. is headquartered in United States of America. It has been publicly traded since 2025.